Kosenske Christopher DDS entered the industry of Oral Surgeons in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6212100, which describes it as a Oral Surgeons. For further clarification, the SIC classifies this business under the code 8021 and described it as a Oral Surgeons. The business provides service to the B2C market.
To acquire more information, please contact Christopher Kosenske by calling (610) 775-0321 during business hours. You can also write to the business’ Single Location at 430 Kenhorst Boulevard, Reading, Pennsylvania PA 19611. You can also visit the company’s website at boulevarddentist.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Kosenske Christopher DDS |
Representative: | Christopher Kosenske |
Place of Business: | 430 Kenhorst Boulevard, Reading, PA 19611 |
Contact Number: | (610) 775-0321 |
Website: | boulevarddentist.com |
Type of Service: | Oral Surgeons |
SIC Number: | 8021 |
NAICS Number: | 6212100 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Kosenske Christopher DDS is a company operating from Berks, Pennsylvania providing professional Oral Surgeons and relevant B2C variables. It was founded in 0 and registered with the SIC code 8021 as Oral Surgeons, and with the NAICS code 6212100 as Oral Surgeons.
With a current employee count of 1 to 4, Kosenske Christopher DDS has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Christopher Kosenske at (610) 775-0321 for related queries, or to locate its Single Location using the coordinates 40.31782,-75.95116.
The Single Location can also be found at the street address 430 Kenhorst Boulevard in Reading, Pennsylvania 19611 and can be engaged online through the company website at boulevarddentist.com, the company Twitter , and Facebook page .